文献速递乳腺癌支持与姑息治疗

全身照射与血液或骨髓移植后乳腺癌风险:BMT幸存者研究

Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report.
PubMed 文献 · J Clin Oncol · 2020-07-16

该回顾性队列研究纳入1974至2014年间接受血液或骨髓移植且存活≥2年的1464例女性患者,中位随访9.3年。多因素分析显示,全身照射(TBI)与异基因移植(HR 3.7)和自体移植(HR 2.6)后乳腺癌风险升高相关;30岁前接受TBI者风险较一般人群高约4.4至4.6倍。

要点

  • TBI与异基因及自体移植后乳腺癌风险升高相关。
  • 30岁前接受TBI者乳腺癌风险较一般人群高4倍以上。
  • 移植前烷化剂暴露与自体移植后乳腺癌风险升高相关。

核心结论

  • TBI与血液或骨髓移植后乳腺癌风险升高相关,尤其见于年轻暴露者;移植前烷化剂暴露亦与风险升高相关,应指导乳腺癌筛查。

研究设计与样本

  • BMT幸存者研究(BMTSS)是一项回顾性队列研究,纳入1974至2014年间接受移植且存活≥2年的患者,排除移植前胸部放疗或乳腺癌病史者。

主要发现

  • 与一般人群相比,30岁前接受TBI者在异基因移植后乳腺癌风险高4.4倍,在自体移植后高4.6倍。

临床怎么用

  • 对接受TBI的BMT幸存者,尤其30岁前暴露者,应加强乳腺癌筛查以实现早期发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To examine the association between total body irradiation (TBI) and subsequent breast cancer in women treated with blood or marrow transplantation (BMT) for hematologic malignancies. PATIENTS AND METHODS: Participants were drawn from the BMT Survivor Study (BMTSS), a retrospective cohort study that included patients who underwent transplantation between 1974 and 2014 and survived for ≥ 2 years after BMT. Patients with pre-BMT chest radiation or a history of breast cancer were excluded. Participants completed the BMTSS survey, which included details regarding breast cancer diagnosis. Subsequent breast cancer was confirmed by pathology report review or physician notes. Cox proportional hazards models assessed the association between TBI and subsequent breast cancer. Standardized incidence ratios were calculated to determine the excess risk of subsequent breast cancer compared with that in the general population. RESULTS: A total of 1,464 female BMT survivors (allogeneic: n = 788; autologous: n = 676) participated, with a median follow-up of 9.3 years from BMT. TBI was used in 660 patients (46%). Thirty-seven women developed subsequent breast cancer (allogeneic: n = 19; autologous: n = 18). Multivariable analysis revealed that exposure to TBI was associated with an increased risk of subsequent breast cancer among allogeneic BMT survivors (hazard ratio [HR], 3.7 [95% CI, 1.2 to 11.8]; P = .03) and autologous BMT survivors (HR, 2.6 [95% CI, 1.0 to 6.8]; P = .048). Pre-BMT exposure to alkylating agents was associated with an increased risk of subsequent breast cancer among autologous BMT survivors (HR, 3.3 [95% CI, 1.0 to 9.0]; P = .05). Compared with that in the general population, exposure to TBI at age < 30 years was associated with a 4.4-fold higher risk of subsequent breast cancer in allogeneic BMT survivors and a 4.6-fold higher risk in autologous BMT survivors. CONCLUSION: The association between TBI and subsequent breast cancer, especially among those exposed at a young age, as well as pre-BMT exposure to alkylating agents, should inform breast cancer screening for early detection.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. McDonald AM, Chen Y, Wu J, et al. Total Body Irradiation and Risk of Breast Cancer After Blood or Marrow Transplantation: A Blood or Marrow Transplantation Survivor Study Report. J Clin Oncol. 2020. PMID: 32673169. doi:10.1200/JCO.20.00231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。